Zyversa Therapeutics Stock Technical Analysis
| ZVSA Stock | 1.07 0.04 3.60% |
As of the 28th of November, ZyVersa Therapeutics maintains the Market Risk Adjusted Performance of 0.5341, standard deviation of 8.19, and Mean Deviation of 4.1. Relative to fundamental indicators, the technical analysis model lets you check existing technical drivers of ZyVersa Therapeutics, as well as the relationship between them.
ZyVersa Therapeutics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as ZyVersa, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to ZyVersaZyVersa |
ZyVersa Therapeutics Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 2.5 | Strong Buy | 1 | Odds |
Most ZyVersa analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand ZyVersa stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of ZyVersa Therapeutics, talking to its executives and customers, or listening to ZyVersa conference calls.
ZyVersa Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
ZyVersa Therapeutics Technical Analysis
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of ZyVersa Therapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.
ZyVersa Therapeutics Trend Analysis
Use this graph to draw trend lines for ZyVersa Therapeutics. You can use it to identify possible trend reversals for ZyVersa Therapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual ZyVersa Therapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.ZyVersa Therapeutics Best Fit Change Line
The following chart estimates an ordinary least squares regression model for ZyVersa Therapeutics applied against its price change over selected period. The best fit line has a slop of 0.03 , which may suggest that ZyVersa Therapeutics market price will keep on failing further. It has 122 observation points and a regression sum of squares at 24.38, which is the sum of squared deviations for the predicted ZyVersa Therapeutics price change compared to its average price change.About ZyVersa Therapeutics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of ZyVersa Therapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of ZyVersa Therapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on ZyVersa Therapeutics price pattern first instead of the macroeconomic environment surrounding ZyVersa Therapeutics. By analyzing ZyVersa Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of ZyVersa Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to ZyVersa Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
ZyVersa Therapeutics November 28, 2024 Technical Indicators
Most technical analysis of ZyVersa help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for ZyVersa from various momentum indicators to cycle indicators. When you analyze ZyVersa charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.09) | |||
| Market Risk Adjusted Performance | 0.5341 | |||
| Mean Deviation | 4.1 | |||
| Coefficient Of Variation | (745.30) | |||
| Standard Deviation | 8.19 | |||
| Variance | 67.13 | |||
| Information Ratio | (0.15) | |||
| Jensen Alpha | (0.85) | |||
| Total Risk Alpha | (2.40) | |||
| Treynor Ratio | 0.5241 | |||
| Maximum Drawdown | 78.93 | |||
| Value At Risk | (9.60) | |||
| Potential Upside | 7.57 | |||
| Skewness | 0.3839 | |||
| Kurtosis | 15.64 |
Complementary Tools for ZyVersa Stock analysis
When running ZyVersa Therapeutics' price analysis, check to measure ZyVersa Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ZyVersa Therapeutics is operating at the current time. Most of ZyVersa Therapeutics' value examination focuses on studying past and present price action to predict the probability of ZyVersa Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ZyVersa Therapeutics' price. Additionally, you may evaluate how the addition of ZyVersa Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |